Melissa B Epperly - Chief Financial Officer, Zentalis Pharmaceuticals, Inc

As of October 4, 2021


Melissa B Epperly Net Worth

  • Net worth is estimated to be at least $21.15M
  • Owns at least 266,685 units of Zentalis Pharmaceuticals, Inc stock
  • Sold an estimated value of $3.82M in the last year at Zentalis Pharmaceuticals, Inc

Melissa B Epperly Trading

  • Largest purchase of shares was 9,611 units , worth over $499.75K on August 20, 2021
  • Largest sale of shares was 17,107 units , worth over $742.32K on April 6, 2021
  • In total has made about 14 transactions over a year
  • Usually trades in December, April and February, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Melissa B Epperly Mailing Address

  • Mailing address is C/o Zentalis Pharmaceuticals, Inc. 530 Seventh Avenue, Suite 2201 New York NY 10018 NY

Zentalis Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Anthony Sun, M.D. 2020 $561,232 - $8,100,645 $5,986,469 $287,375 $108,678 $15,044,399
Anthony Sun, M.D. 2019 $455,091 - - $918,000 $204,971 - $1,577,882
Kevin Bunker, Ph.D. 2020 $428,771 - $2,580,864 $2,993,235 $179,550 $91,174 $6,273,594
Kevin Bunker, Ph.D. 2019 $360,024 - - $275,400 $144,010 - $779,434
Alexis M. Pinto 2020 $136,923 - - $6,234,468 $152,000 $10,511 $6,533,902
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1725160/000172516021000099/proxystatement-2021.htm

Zentalis Pharmaceuticals, Inc Insider Trading

  • The most recent transaction was 10,000 units sold on October 4, 2021 by Cam Gallagher worth over $661.49K
  • In the last year, insiders at Zentalis Pharmaceuticals, Inc sold an estimated value of $75.41M and bought an estimated value of $14M
  • The most active traders are Kevin D Bunker, Chief Operating Officer,  Cam Gallagher, Director,  and Anthony ySun, President & CEO
  • Insider trading is most common in April, with the busiest year in 2021

Zentalis Pharmaceuticals, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1